1 | 9060X | - | - | - | - | 2件: 13 13, 149 💬
|
2 | Anatomical landmark-guided suprascapular nerve block | - | - | - | - | 1件: 149 149 💬
|
3 | Baclofen | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 7件: 2 2, 10, 13, 18, 65, 149, 206 💬
|
4 | Berg balance scale | - | - | - | - | 4件: 6 6, 13, 113, 149 💬
|
5 | Botox | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 36, 149, 226 💬
|
6 | Botulinum toxin | - | - | - | - | 3件: 6 6, 13, 149 💬
|
7 | Botulinum toxin A | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 4件: 13 13, 51, 149, 226 💬
|
8 | Botulinum toxin type A | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 11件: 2 2, 5, 6, 7, 13, 15, 17, 47, 113, 149, 171 💬
|
9 | Brivaracetam | 1件: Brivaracetam Brivaracetam | 1件: Brivaracetam
Brivaracetam
💬
| 1件: SV2 SV2 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 2件: 149 149, 309 💬
|
10 | BTX-A | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 2件: 6 6, 149 💬
|
11 | Capture | 1件: Bifenthrin Bifenthrin | - | - | - | 2件: 46 46, 149 💬
|
12 | Carbon | 1件: Activated charcoal Activated charcoal | 1件: Charcoal, activated
Charcoal, activated
💬
| - | - | 4件: 6 6, 97, 149, 235 💬
|
13 | Conservative rehabilitation | - | - | - | - | 1件: 149 149 💬
|
14 | Edonerpic | 1件: Edonerpic Edonerpic | - | - | - | 1件: 149 149 💬
|
15 | Ezetimibe | 1件: Ezetimibe Ezetimibe | 1件: Ezetimibe
Ezetimibe
💬
| 1件: NPC1L1 NPC1L1 💬
| 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 4件: 79 79, 93, 149, 260 💬
|
16 | Fenfluramine | 1件: Fenfluramine Fenfluramine | 2件: Fenfluramine hydrochloride
Fenfluramine hydrochloride
,
Fenfluramine
💬
| 5件: HTR1 HTR1, HTR2, HTR2, SIGMAR1, SLC6A4 💬
| 11件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 | 4件: 140 140, 144, 145, 149 💬
|
17 | Gait analysis | - | - | - | - | 1件: 149 149 💬
|
18 | HC-58 | - | - | - | - | 1件: 149 149 💬
|
19 | Lacosamide | 1件: Lacosamide Lacosamide | 1件: Lacosamide
Lacosamide
💬
| 2件: SCN3A SCN3A, SCN9A 💬
| 1件: Taste transduction Taste transduction 💬 | 4件: 2 2, 46, 149, 298 💬
|
20 | Levetiracetam | 1件: Levetiracetam Levetiracetam | 1件: Levetiracetam
Levetiracetam
💬
| 1件: SV2 SV2 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 7件: 2 2, 4, 6, 13, 34, 149, 307 💬
|
21 | Measurement OF multifidus and gastrocnemius muscle thickness with ultrasound | - | - | - | - | 1件: 149 149 💬
|
22 | Medicinal AIR | - | - | - | - | 1件: 149 149 💬
|
23 | Melatonin | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 16件: 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
|
24 | Meopa | - | - | - | - | 1件: 149 149 💬
|
25 | Nociceptor flexor reflex | - | - | - | - | 1件: 149 149 💬
|
26 | Onabotulinumtoxina FOR injection | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 149 149 💬
|
27 | Oxygen | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬
| - | - | 13件: 22 22, 49, 70, 85, 86, 88, 149, 168, 235, 271, 298, 299, 330 💬
|
28 | Padsevonil | 1件: Padsevonil Padsevonil | 1件: Padsevonil
Padsevonil
💬
| 3件: SV2 SV2, SV2, SV2 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 149 149 💬
|
29 | Sodium oxybate | 1件: Sodium oxybate Sodium oxybate | 1件: Sodium oxybate
Sodium oxybate
💬
| - | - | 2件: 6 6, 149 💬
|
30 | THE patients' parents have TO complete THE vineland II adaptive behavior scales scoring, THE sleep disturbance scale FOR children (sdsc) and horne & ostberg circadian typology questionnaire | - | - | - | - | 1件: 149 149 💬
|
31 | Time delay treatment OF botulinum toxin | - | - | - | - | 1件: 149 149 💬
|
32 | Tocilizumab | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 24件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
|
33 | Triheptanoin | 1件: Triheptanoin Triheptanoin | 1件: Triheptanoin
Triheptanoin
💬
| - | - | 10件: 2 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 💬
|
34 | Ultrasound-guided suprascapular nerve block | - | - | - | - | 1件: 149 149 💬
|
35 | Upper limb muscle block | - | - | - | - | 1件: 149 149 💬
|
36 | Virtual balance training | - | - | - | - | 1件: 149 149 💬
|
37 | Whole exome sequencing | - | - | - | - | 6件: 2 2, 6, 65, 120, 127, 149 💬
|